Link Cell Therapies
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $102M
Investors
- 9
About Link Cell Therapies
Link Cell Therapies, Inc is a biotechnology company specializing in innovative cancer treatments, established in 2022 in South San Francisco, US., and Brian Slingerland. Link Cell Therapies specializes in innovative cancer cell therapies, focusing on developing CAR T agents designed for solid tumors. Their core product offerings revolve around a proprietary AND-gate CAR T technology that enhances specificity and safety compared to existing therapies by requiring simultaneous expression of cancer targets to activate cell cytotoxicity. This technology aims to address significant challenges in treating solid tumors and certain hematologic cancers, with potential applications in pediatric oncology. Their therapeutic programs target healthcare providers and oncologists across North America, Europe, and Asia, where advanced cancer treatments are in high demand. Link Cell Therapies generates revenue through partnerships and collaborations with biotechnology firms and healthcare institutions involved in cancer treatment and research. Their revenue model typically involves joint ventures or licensing agreements for the development and commercialization of their CAR T therapies. Collaborations with pharmaceutical companies integrate their technologies into existing treatment pipelines, which may include milestone payments and royalties based on sales of approved therapies.
Who invested in Link Cell Therapies
9 investors across 3 rounds
See all investors in Link Cell Therapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Link Cell Therapies
Who invested in Link Cell Therapies?
Link Cell Therapies has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Link Cell Therapies raised?
Link Cell Therapies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Link Cell Therapies last raise money?
Link Cell Therapies's most recent round on record is a Series A, in Sep 2026.
What does Link Cell Therapies do?
Link Cell Therapies, Inc is a biotechnology company specializing in innovative cancer treatments, established in 2022 in South San Francisco, US.
Where is Link Cell Therapies headquartered?
Link Cell Therapies is headquartered in San Carlos, US.
Which VCs invest in companies like Link Cell Therapies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Link Cell Therapies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Link Cell Therapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.